Amir Nicknam, MD
Occupational Medicine · North Las Vegas, NVNPI 1063530434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Qiagen, LLC at 41.2% of the total. Reporting peaked in 2019 at $452 and has fallen 96.4% since, to $16 in 2025.
Across 23 payments — averaging $48.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Qiagen, LLC$457
- Insulet Corporation$332
- Lilly USA, LLC$122
- Johnson & Johnson$105
- Exact Sciences$27
- Dynavax Technologies Corporation$23
- plus $42 from 3 others
What the payments were for
- Food & beverage$1,109100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Qiagen, LLC | 5 | $457 |
| Insulet Corporation | 10 | $332 |
| Lilly USA, LLC | 1 | $122 |
| Johnson & Johnson | 1 | $105 |
| Exact Sciences | 2 | $27 |
| Dynavax Technologies Corporation | 1 | $23 |
| Boston Scientific | 1 | $16 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MDX QUANTIFERON$394
- Omnipod$256
- JARDIANCE$122
- XARELTO$105
How this compares
Too few occupational medicine providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $36,144 |
| JardianceEmpagliflozin | 17 | $20,257 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $1,984 |
| Gabapentin | 85 | $1,312 |
| Atorvastatin Calcium | 155 | $1,128 |
| Metoprolol Succinate | 66 | $977 |
| Losartan Potassium | 101 | $875 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $826 |
| Pantoprazole Sodium | 29 | $694 |
| Fluticasone Propionate | 56 | $609 |
| Omeprazole | 27 | $588 |
| Indomethacin | 12 | $557 |
| Amlodipine Besylate | 114 | $521 |
| Metformin Hcl | 76 | $429 |
| Lisinopril | 69 | $417 |
Paid to pharmacies, not to this prescriber.
Other occupational medicine in North Las Vegas
- Jeff MoonNorth Las Vegas$293
- Judith SalzNorth Las Vegas$0
- Josephine SaludezLas Vegas$637
- Mikel MeyerSparks$155
- Matthew KiokLas Vegas$122
- Robert DavisLas Vegas$120
- Maria PalaciosLas Vegas$105
- Troy RossReno$89
- Robert ErwinSparks$82
- Ceylon CaszattLas Vegas$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.